Analysis of gene mutations and clinical features in elderly patients with melanoma

王轩,斯璐,孔燕,盛锡楠,崔传亮,迟志宏,李思明,毛丽丽,连斌

DOI: https://doi.org/10.3760/cma.j.issn.0254-9026.2013.09.015

2013-01-01

Abstract:Objective To investigate the gene mutation status in Chinese elderly patients with melanoma and to explore the correlation of gene mutation with clinical characteristics and prognosis.Methods Melanoma tissue samples from Chinese elderly patients were analyzed for gene mutations of KIT,BRAF and NRAS in genomic DNA by polymerase chain reaction(PCR) amplification and Sanger sequencing.The correlations of gene mutations with clinicopathologic features and prognosis were statistically analyzed.Results The most common pathological subtypes were acral and mucosal among 122 elderly patients with melanoma.The median overall survival time was 53 months.Somatic mutation in the KIT gene was 13.9％,in which mutations exon 11 L576P mutation was the most common mutation type(4 cases).Mutation in the BRAF gene was 18.0％,in which V600E mutation was the most common mutation type(86.0％),and the incidence of BRAF mutation was increased in patients with non-chronic sun-damaged disease as compared with other subtypes(85.7％,P＜0.05).The mutation in the NRAS gene was 7.4％,in which Q61K mutation was the most common type.The survival time was shorter in patients with KIT mutation than in patients with wild type KIT gene(33.0 months vs.55.0 months,P＜0.05).Conclusions KIT mutation is an adverse prognostic factor for Chinese elderly patients with melanoma.KIT and BRAF gene mutations are frequent in elderly patients with melanoma,which provides a preliminary theoretical basis for individualized targeted therapy with KIT and BRAF inhibitors in elderly patients with melanoma.